Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
Hepatitis C Treatment Market to Exceed US$ 71.13 Bn by the end of 2024

The global hepatitis C treatment market was valued at US$ 23.9 Bn in 2015 and is estimated to be valued at US$ 26.6 Bn by 2016. The market is expected to reach a valuation of US$ 71.13 Bn by the end of 2024, reflecting a cumulative annual growth rate of 13.1% over the forecast period.

Published
04 March 2019
From
Honest Businessman
A new way to pay for innovative drugs, provide universal access and not break the bank

Louisiana, which has a severe hepatitis C problem, is on the cusp of proving to other states that drug companies can make the money they need, while every Medicaid recipient who needs a cure gets one. The state is now on a path to secure immediate treatment for all infected prisoners and people on Medicaid by buying a license from a drug company. It is a concept that can be applied to other ground breaking remedies.

Published
28 February 2019
From
The Conversation
Councils in London may block additional PrEP places proposed for gay and bisexual men

NHS England announced today that whilst the PrEP Impact trial will double the number of places on the trial in clinics outside London, local authority commissioners in London are still considering what proportion of the proposed additional places they wish to accept. Fifty per cent of PrEP Impact Trial places are for London clinics.

Published
28 February 2019
From
National AIDS Trust
It’s Time For Government To Get To Grips With The Nation’s Sexual Health

Ian Green of Terrence Higgins Trust: As demand for sexual health services rises by 13%, funding for public health has been continuously cut, with sexual health service budgets being cut by a quarter.

Published
06 February 2019
From
Huffington Post
EU now world's third-biggest spender in the fight against HIV/AIDS, TB and malaria

Commission R&D funding for neglected diseases rose by 50 per cent in 2017. The UK and US remain the biggest funders - and UK spending increased by 89 per cent, says Australian charity.

Published
25 January 2019
From
Science Business
UK court dismisses AbbVie's legal challenge against the NHS

The High Court has dismissed a legal challenge by US pharmaceutical firm AbbVie against the National Health Service (NHS) England's procurement deal for drugs to treat and cure hepatitis C. The decision means that the plan to eliminate the virus in England remains on track.

Published
25 January 2019
From
The Lancet (free registration required)
Why Are Wealthy Nations Becoming Less Inclined to Fight Global AIDS?

Bono sums up the root of the problem with one word: populism.

Published
25 January 2019
From
Poz
HIV care is threatened by proposed changes to Medicare Part D

Optimal HIV care includes early and uninterrupted access to effective antiretroviral medications. Proposed changes to Medicare Part D threatens that.

Published
25 January 2019
From
STAT
HIV prevention gridlock as proposed extra NHS PrEP delayed

A proposal to double the number of people able to access PrEP (a highly effective HIV prevention pill) through the PrEP Impact Trial has been delayed by the trial oversight board. This is despite the fact that NHS England has agreed to fund the additional 13,000 places. Currently, many clinics have no spaces for additional patients and are turning away people at high risk of HIV, some of whom are going on to acquire the virus.

Published
23 January 2019
From
National AIDS Trust
This Is What It’s Like To Lose Your Local Sexual Health Clinic Under Austerity

In a new series, HuffPost UK is examining how shrinking local budgets are affecting people’s daily lives. These are stories of what it’s like to lose, in a society that is quietly changing.

Published
23 January 2019
From
Huffington Post

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.